Minerva Neurosciences | NERV - PE Price to Earnings


Minerva Neurosciences reported 14.32 in PE Price to Earnings for its fiscal quarter ending in March of 2021.





Pe Change Date
Acadia Pharmaceuticals USD 11.61 2.09 Dec/2025
Adma Biologics USD 17.25 4.43 Sep/2025
ALKERMES USD 19.54 4.64 Dec/2025
AstraZeneca USD 27.29 5.8 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Cipla INR 27.74 3.55 Dec/2025
Clal Biotechnology ILS 11.67 2.62 Dec/2022
CSL USD 16.16 9.59 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
Grifols EUR 12.27 4.84 Sep/2025
Halozyme Therapeutics USD 23.16 7.7 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
J&J USD 23.62 0.86 Dec/2025
Merck USD 13.92 5.08 Dec/2025
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Novartis USD 15.74 0.15 Sep/2025
Novavax 2.28 346.03 Mar/2025
Pfizer USD 14.48 5.18 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
Takeda JPY 235.05 184.95 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023